News
Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most active stocks to buy according to analysts. On June 13, Ethris announced a collaboration with Thermo Fisher Scientific. The partnership ...
Life sciences and specialty diagnostics giant Thermo Fisher Scientific Inc. (NYSE: TMO) said it has received a $94.5 million contract to supply the U.S. Navy with advanced radiation detection systems, ...
Thermo Fisher Scientific (NYSE:TMO) recently made headlines by entering a collaboration with Ethris GmbH to advance mRNA solutions and putting a $4 billion price tag on part of its diagnostics unit ...
Thermo Fisher Scientific (NYSE:TMO) recently made headlines by entering a collaboration with Ethris GmbH to advance mRNA solutions and putting a $4 billion price tag on part of its diagnostics ...
Thermo Fisher Scientific has put part of its diagnostics unit up for sale for about $4bn in the latest move by a life sciences company to attempt to offload some of its low-growth assets.
Thermo Fisher launches the Orbitrap Astral Zoom and Orbitrap Excedion Pro MS at ASMS 2025, advancing proteomics and drug development.
Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary. Read why TMO stock is a Strong Buy.
Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development of genetic medicines.
Thermo Fisher Scientific announced a $2 billion investment in US operations over the next four years to bolster domestic innovation and manufacturing capabilities in the life sciences sector.
Conclusion Thermo Fisher was priced for perfection in January near $600, and we got a lot of imperfection in the form of slow growth plus tariff and fiscal policy headwinds.
Thermo Fisher Scientific CIO Ryan Snyder believes business strategy and tech strategy should be woven together and that data should be co-owned across the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results